Maskot/DigitalVision via Getty Images Thesis Inhibrx Biosciences, Inc. ( INBX ) reported a Q4 2025 GAAP EPS of -$2.11, a figure that missed expectations by about $0.03. Again, there were continued losses typical of a clinical-stage biotech. The company also ended the year with a decent cash sum of $124.2 million, which should give a moderate liquidity cushion; however, we did see the introduction ...
Maskot/DigitalVision via Getty Images Thesis Inhibrx Biosciences, Inc. ( INBX ) reported a Q4 2025 GAAP EPS of -$2.11, a figure that missed expectations by about $0.03. Again, there were continued losses typical of a clinical-stage biotech. The company also ended the year with a decent cash sum of $124.2 million, which should give a moderate liquidity cushion; however, we did see the introduction of some debt. You see, to strengthen their financial position, Inhibrx secured an additional $75 million in financing this month via an amended loan agreement with Oxford Finance. So, this is a reliance on external funding to support ongoing operations rather than introducing dilution. Going forward, I see Inhibrx as a pretty high-risk, catalyst-driven biotech where the valuation is almost entirely dependent on their two main pipeline assets. I see ozekibart’s clinical and regulatory success in 2026 as the next stock driver, so I'm choosing to focus on this candidate; however, INBRX-106 has some upcoming interim ORR data for randomized, first-line HNSCC that investors should keep an eye out for. As for ozekibart, the upcoming 2026 data readouts and BLA submission drive the bull case. In that sense, I would be on hold-rated until those key data readouts, as the current valuation is already pricing in a pretty reasonable upside, as I'll explain. FY25 overview I think Inhibrx’s FY25 financials are best understood as somewhat of a reset year. Back in 2024, there was a transformative transaction with Sanofi, which pretty much fundamentally altered both the company’s income profile and its cost structure. As a result, this year we saw a big collapse in reported earnings, down from about $1.7 billion in net income in 2024 to a $140.1 million net loss in 2025. We can put this down to the disappearance of the hefty gain booked in 2024 from the sale of INBRX-101 and some other associated assets. We can see that in 2024, other income alone contributed just over $2.0 billion, whereas i...
Beyond Meat ( BYND ) on Wednesday said it will delay reporting its fourth-quarter and full-year 2025 financial results to March 31, citing material weakness in controls and immaterial accounting errors in prior quarterly statements. Consensus for FY25 and Q4 revenues are $275.85M and $62M. BYND -0.01% premarket to $0.6867. Source: Press Release More on Beyond Meat Beyond Meat's Debt Reduction Boug...
Beyond Meat ( BYND ) on Wednesday said it will delay reporting its fourth-quarter and full-year 2025 financial results to March 31, citing material weakness in controls and immaterial accounting errors in prior quarterly statements. Consensus for FY25 and Q4 revenues are $275.85M and $62M. BYND -0.01% premarket to $0.6867. Source: Press Release More on Beyond Meat Beyond Meat's Debt Reduction Bought Time, Not A Turnaround Beyond Meat: The Situation Remains Difficult Beyond Meat Q4 2025 Earnings Preview Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag Seeking Alpha’s Quant Rating on Beyond Meat
Shiffrin holds off challenge from Germany’s Emma Aicher US star ties record set by Annemarie Moser-Pröll in 1970s Mikaela Shiffrin secured a record-tying sixth women’s overall World Cup skiing title by holding off a challenge from Germany’s Emma Aicher in the final race of the season. Shiffrin needed only to finish in the top 15 of Wednesday’s giant slalom in Lillehammer, and the American secured ...
Shiffrin holds off challenge from Germany’s Emma Aicher US star ties record set by Annemarie Moser-Pröll in 1970s Mikaela Shiffrin secured a record-tying sixth women’s overall World Cup skiing title by holding off a challenge from Germany’s Emma Aicher in the final race of the season. Shiffrin needed only to finish in the top 15 of Wednesday’s giant slalom in Lillehammer, and the American secured that before Aicher had even began her second run. Shiffrin finished 11th and Aicher – who needed to win the race and hope that Shiffrin finished 16th or worse to clinch her first title – finished 12th. Shiffrin was only 17th after the first run but came down in first position in the second and then clinched it when the next two starters placed behind her. After she was told she had won the title, Shiffrin dropped to her knees, put her hand to her face and appeared to be in tears as she asked her team, “Are you sure?” Continue reading...
Qnity Electronics (NYSE:Q) announced a collaboration with NVIDIA to use AI and high performance computing for materials research in semiconductor manufacturing. The company also opened a new large scale manufacturing facility in Delaware to expand capacity for advanced semiconductor components, including specialized CMP pads. Qnity Electronics, trading at $118.34, is moving to align its business w...
Qnity Electronics (NYSE:Q) announced a collaboration with NVIDIA to use AI and high performance computing for materials research in semiconductor manufacturing. The company also opened a new large scale manufacturing facility in Delaware to expand capacity for advanced semiconductor components, including specialized CMP pads. Qnity Electronics, trading at $118.34, is moving to align its business with growing AI related demand in chip production. The stock is up 39.3% year to date and 4.2%...
DKosig As the artificial intelligence landscape continues to rapidly evolve and attract greater scrutiny, the probability of the Citrini scenario unfolding has gained notable traction in prediction markets. For reference, the Citrini scenario describes a hypothetical economic downturn triggered by the rapid spread of AI. In this framework, automation accelerates job displacement, which erodes cons...
DKosig As the artificial intelligence landscape continues to rapidly evolve and attract greater scrutiny, the probability of the Citrini scenario unfolding has gained notable traction in prediction markets. For reference, the Citrini scenario describes a hypothetical economic downturn triggered by the rapid spread of AI. In this framework, automation accelerates job displacement, which erodes consumer demand and creates a self-reinforcing cycle that pushes the economy into a prolonged structural slump. According to Kalshi data, traders are currently assigning about a 26.9% probability to this scenario unfolding—marking a sharp increase from late February, when odds were closer to 10%. On February 28, when the U.S.–Iran conflict escalated with coordinated airstrikes, the market was pricing in only a roughly one-in-ten chance of the Citrini scenario materializing, highlighting how expectations have shifted higher alongside rising geopolitical tensions. Market Tracking ETFs: ( DIA ), ( DDM ), ( DOG ), ( DXD ), ( SDOW ), ( SPY ), ( VOO ), ( IVV ), ( RSP ), ( SSO ), ( UPRO ), ( SH ), ( SDS ), ( SPXU ), ( QQQ ), ( QQQM ), ( TQQQ ), ( QID ), and ( SQQQ ). More on markets AI now dominates equities, bonds, and venture capital flows, Apollo warns Cantor Fitzgerald sees the current market pullback as a possible opportunity BNP Paribas raises 2026 inflation outlook as it signals a new 3% era Wells Fargo sees the U.S. economy weathering an oil shock as inflation risks stay contained $14T debt wave looms, threatening higher rates and wider spreads, Apollo warns
MIAMI, March 25, 2026--Addigy, the leader in Apple MDM, significantly expanded its European presence and appointed Michel van den Berg to head international sales.
MIAMI, March 25, 2026--Addigy, the leader in Apple MDM, significantly expanded its European presence and appointed Michel van den Berg to head international sales.
Amazon loves to manufacture an event. March is historically a dry spell for deals; however, with Amazon’s third annual Big Spring Sale , which starts today and runs through March 31st, the retail behemoth is hoping to lure in would-be shoppers with the promise of steep(ish) savings and discounts on more seasonal, spring-centric items to hold folks over until Prime Day surfaces at the onset of summ...
Amazon loves to manufacture an event. March is historically a dry spell for deals; however, with Amazon’s third annual Big Spring Sale , which starts today and runs through March 31st, the retail behemoth is hoping to lure in would-be shoppers with the promise of steep(ish) savings and discounts on more seasonal, spring-centric items to hold folks over until Prime Day surfaces at the onset of summer . The bulk of the deals we’re seeing right now aren’t quite on par with Black Friday or Prime Day, and, as with most shopping events, not everything on sale is worth picking up. That said, Amazon’s latest sale is one of the first big opportunities we’ve seen this year to save — and bypass some tariff-induced pain — especially since some of our favorite gadgets are currently matching their lowest prices to date, including headphones, robot vacuums, and a slew of charging accessories. To help you sift through it all, we’re focusing squarely on the gadgets that are actually worth picking up, many of which we’ve tested and recommend even at full price. You’re not limited to Amazon, either. Retailers like Best Buy and Walmart are offering the same deals in a lot of cases, meaning you don’t necessarily need to succumb to shopping at the so-called “Everything Store” just to save a buck (or 50). Speaker deals Echo Dot Max The Echo Dot Max features a flat design and a redesigned sound system, which delivers nearly three times the bass as its predecessor. It also offers improved conversation detection and better noise filtering, thanks to Amazon’s new AZ3 chip. Read our review . Where to Buy: $99.99 $74.99 at Amazon $99.99 $74.99 at Best Buy $99.99 $74.99 at Target Sonos Move 2 With double the battery life of its predecessor and better-sounding stereo audio, the Sonos Move 2’s improvements don’t stop there. It supports line-in audio, can stream Bluetooth audio to other Sonos speakers, and more. Read our review. Where to Buy: $499 $399 at Amazon $499 $399 at Best Buy $499 $399 at S...
Harvey, a startup that develops artificial intelligence for law firms, has raised $200 million in a new funding round that values the company at $11 billion. The company will use the funds to expands its AI agents and grow its legal engineering teams that’s embedded with the customers, Harvey said in a statement on Wednesday. The round is co-led by existing investors GIC and Sequoia. Harvey was va...
Harvey, a startup that develops artificial intelligence for law firms, has raised $200 million in a new funding round that values the company at $11 billion. The company will use the funds to expands its AI agents and grow its legal engineering teams that’s embedded with the customers, Harvey said in a statement on Wednesday. The round is co-led by existing investors GIC and Sequoia. Harvey was valued at $8 billion when it raised funds in December. Legal AI startups have boomed as tools powered by large language models promise to save lawyers time on grunt work like summarizing large documents, looking for red flags in due diligence, and drafting. Swedish legal startup Legora raised $550 million earlier this month, hitting a $5.55 billion valuation, to fund its US expansion. Harvey said legal work is going through a fundamental shift as more complex tasks are performed by AI agents. The company said it has more than 25,000 custom AI agents, executing work across M&A, due diligence, contract drafting and document review. Its customers include Comcast Corp. ’s NBCUniversal , HSBC Holdings Plc , and DLA Piper International . The fundraising round brings the total capital Harvey has raised to more $1 billion. Existing investors Andreessen Horowitz , Coatue , Conviction Partners, Elad Gil , Evantic , and Kleiner Perkins also participated.
BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results for 2025 as of December 13, 2025.
BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results for 2025 as of December 13, 2025.
Over two days in October 2025, up to 10,000 people are believed to have been massacred; a further 40,000 civilians from the Sudanese city are still unaccounted for. This is the story of what happened In the pistachio green Toyota Land Cruiser rattling over the desert plain, Aboud Khater pressed his foot to the floor. Behind, the sun rose above El Fasher. Smoke belched from the stricken city. Khate...
Over two days in October 2025, up to 10,000 people are believed to have been massacred; a further 40,000 civilians from the Sudanese city are still unaccounted for. This is the story of what happened In the pistachio green Toyota Land Cruiser rattling over the desert plain, Aboud Khater pressed his foot to the floor. Behind, the sun rose above El Fasher. Smoke belched from the stricken city. Khater was driving the last vehicle of the final evacuation convoy from El Fasher. It was 5:45am on 27 October 2025. He couldn’t have waited any longer. The historic capital of Sudan’s sprawling region of Darfur would capitulate in the next two hours. Continue reading...
Innovation Beverage Group ( IBG ) on Wednesday said it has acquired a controlling interest in BlockFuel Energy, a Texas -based energy corporation. This transaction represents a significant milestone towards the proposed merger between both companies, which they anticipate closing in the coming weeks. On March 16, 2026, IBG entered into a Share Exchange Agreement with certain shareholders of BFE pu...
Innovation Beverage Group ( IBG ) on Wednesday said it has acquired a controlling interest in BlockFuel Energy, a Texas -based energy corporation. This transaction represents a significant milestone towards the proposed merger between both companies, which they anticipate closing in the coming weeks. On March 16, 2026, IBG entered into a Share Exchange Agreement with certain shareholders of BFE pursuant to which IBG acquired 127,628 shares of BFE common stock, representing approximately 51% of BFE’s outstanding equity. As consideration for those shares, IBG issued warrants to purchase an aggregate of 3.81M ordinary shares of IBG at an exercise price of $0.0001 per share, which are not exercisable until shareholder approval and approval by Nasdaq are obtained. The warrant shares represent 45.9% of the issued and outstanding shares of IBG and will represent 51% of the merger consideration payable at the time of the closing of the merger. As part of the transaction, IBG also provided BFE with a $2.5 million unsecured loan, which facilitated the repurchase and cancellation of certain outstanding BFE shares. Upon completion of the merger, the combined company is expected to operate under the BlockFuel Energy name, with IBG’s existing beverage business transitioning into an Australian-based subsidiary led by IBG’s CEO Sahil Beri as President. The new parent company will focus on scaling its U.S. onshore oil and gas operations. BlockFuel Energy is focused on the acquisition, development, and operation of oil and gas assets, with current operations primarily located in the United States , including acreage positions in Oklahoma . IBG -11.57% premarket to $1.07. Source: Press Release More on Innovation Beverage Group Limited Innovation Beverage Group prices $6M public offering Financial information for Innovation Beverage Group Limited